Aluminium sulfate clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How each study uses aluminium sulfate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
6 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 4
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Manav Rachna International Institute of Research and Studies (1) · SK Bioscience Co., Ltd. (1) · Pfizer (1) · PATH Vaccine Solutions (1) · Alexey Mukhin (1)
Often tested with
Tested in the same studies.
Aluminum sulfate (6) · ACU-026-001 (1) · NBP2001 (1) · VLA15 (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test aluminium sulfate.
- Dec 2026Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIVPhase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Studies
Open first, then newest update. How each study uses aluminium sulfate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Clinical Outcomes of Different Mouth Rinses During Clear Aligner Orthodontic TherapyCompletedNot applicableManav Rachna International Institute of Research and StudiesNCT07865416Written as Alum Mouth RinseHow we know
- Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIVActive, not recruitingPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT05903339Written as Alum 500 mcgHow we know
- Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)CompletedPhase 1SK Bioscience Co., Ltd.NCT04760743Written as NBP2001 adjuvanted with alum (RBD 30μg/dose)How we know
- Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme BorreliosisCompletedPhase 1PfizerNCT03010228Written as VLA15 with AlumHow we know
- Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy AdultsCompletedPhase 1PATH Vaccine SolutionsNCT01537185Written as SPWCV+Alum 100 mcgHow we know
- Improving the Efficacy of Anti-Nicotine ImmunotherapyCompletedPhase 2Alexey MukhinNCT01280968Written as NIC002 in Aluminum hydroxide (Alum)How we know
Given beside what is tested · 3 — aluminium sulfate is usual care or a partner of the new treatment
- Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIVCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT05781542Written as AlumHow we know
- Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsCompletedPhase 2Novartis PharmaceuticalsNCT01097096Written as AlumHow we know
- Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused DiarrheaCompletedPhase 1U.S. Army Medical Research and Development CommandNCT02067676Written as Alhydrogel®, aluminum hydroxide adjuvant (alum)How we know
As the comparator · 1 — what is tested is compared with aluminium sulfate
Codes
What other systems call aluminium sulfate · ClinicalTrials.gg INT033293
- UNII (FDA) I7T908772FALUMINUM SULFATE ANHYDROUSConfirmed FDA, Wikidata
- RxNorm 1593147Confirmed FDA, Wikidata
- Wikidata Q421857aluminium sulfateConfirmed FDA, Wikidata
- DrugBank DB11239One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | I7T908772F | ALUMINUM SULFATE ANHYDROUS | Confirmed FDA, Wikidata |
| RxNorm | 1593147 | — | Confirmed FDA, Wikidata |
| Wikidata | Q421857 | aluminium sulfate | Confirmed FDA, Wikidata |
| DrugBank | DB11239 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.